MINAKEM

MINAKEM is a fully integrated development partner and commercial manufacturer for pharmaceutical companies, specializing in API manufacturing, custom development, custom manufacturing, and production of key intermediates and building blocks. The company boasts strong R&D technical centers, advanced analytical services, and a talented team ensuring high-quality services in Quality Assurance, Regulatory Affairs, Safety, Health, and Environment. With expertise in complex multi-step synthesis, pressure chemistry, chiral synthesis, and more, MINAKEM operates in three FDA and local health agency-approved sites in France, Belgium, and Canada. As part of the Minafin Group, MINAKEM has access to a wide array of technologies, resources, and capabilities, enhancing its ability to meet client needs. The company secured a €14.50M Venture Round investment from Minafin on 12 March 2018.